Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-117046
Filing Date
2024-10-24
Accepted
2024-10-24 16:05:05
Documents
1
Period of Report
2024-10-22

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 5449
  Complete submission text file 0000950170-24-117046.txt   8172
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DEEP TRACK CAPITAL, LP 200 GREENWICH AVENUE, 3RD FLOOR GREENWICH CT 06830
Business Address
KROIN DAVID (Reporting) CIK: 0001397513 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34207 | Film No.: 241392623

Mailing Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830
Business Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830 2034090812
Deep Track Capital, LP (Reporting) CIK: 0001856083 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-34207 | Film No.: 241392624

Mailing Address C/O WALKERS CORPORATE LIMITED 190 ELGIN AVE GEORGE TOWN E9 KY1-9001
Business Address C/O WALKERS CORPORATE LIMITED 190 ELGIN AVE GEORGE TOWN E9 KY1-9001 203-409-0810
Deep Track Biotechnology Master Fund, Ltd. (Reporting) CIK: 0002015536 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-34207 | Film No.: 241392625